These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23817325)

  • 21. Network Pharmacology-Based Approaches of
    Baek SY; Lee EH; Oh TW; Do HJ; Kim KY; Park KI; Kim YW
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32178308
    [No Abstract]   [Full Text] [Related]  

  • 22. To pee or not to pee: ammonia hypothesis of hepatic encephalopathy revisited.
    Mpabanzi L; Olde Damink SW; van de Poll MC; Soeters PB; Jalan R; Dejong CH
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):449-54. PubMed ID: 21537121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory effects of etanercept (TNFR:Fc) and its use in a patient with Crohn's disease.
    Srivastava MD
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):125-41. PubMed ID: 11458980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perispinal etanercept: potential as an Alzheimer therapeutic.
    Griffin WS
    J Neuroinflammation; 2008 Jan; 5():3. PubMed ID: 18186919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.
    Wright G; Noiret L; Olde Damink SW; Jalan R
    Liver Int; 2011 Feb; 31(2):163-75. PubMed ID: 20673233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
    Tukov FF; Luyendyk JP; Ganey PE; Roth RA
    Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etanercept. Soluble tumour necrosis factor receptor, TNF receptor fusion protein, TNFR-Fc, TNR 001, Enbrel.
    Drugs R D; 1999 Jan; 1(1):75-7. PubMed ID: 10565993
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure.
    Chastre A; Bélanger M; Nguyen BN; Butterworth RF
    Liver Int; 2014 Mar; 34(3):353-61. PubMed ID: 23910048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of tumor necrosis factor alpha blockade in the treatment of congestive heart failure.
    Lisman KA; Stetson SJ; Koerner MM; Farmer JA; Torre-Amione G
    Congest Heart Fail; 2002; 8(5):275-9. PubMed ID: 12368591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic inflammation and ammonia in hepatic encephalopathy.
    Tranah TH; Vijay GK; Ryan JM; Shawcross DL
    Metab Brain Dis; 2013 Mar; 28(1):1-5. PubMed ID: 23224356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical science workshop: targeting the gut-liver-brain axis.
    Patel VC; White H; Støy S; Bajaj JS; Shawcross DL
    Metab Brain Dis; 2016 Dec; 31(6):1327-1337. PubMed ID: 26446022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etanercept treatment of rheumatoid arthritis in the "real world".
    Smith MD
    Ann Rheum Dis; 2003 Jan; 62(1):95-6; author reply 96. PubMed ID: 12480688
    [No Abstract]   [Full Text] [Related]  

  • 34. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
    Pastor N; Betlloch I; Pascual JC; Blanes M; Bañuls J; Silvestre JF
    Clin Exp Dermatol; 2006 Jan; 31(1):152-3. PubMed ID: 16309525
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases.
    Pérez-Alvarez R; Díaz-Lagares C; García-Hernández F; Lopez-Roses L; Brito-Zerón P; Pérez-de-Lis M; Retamozo S; Bové A; Bosch X; Sanchez-Tapias JM; Forns X; Ramos-Casals M;
    Medicine (Baltimore); 2011 Nov; 90(6):359-371. PubMed ID: 22033451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
    Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy.
    Luo M; Liu H; Hu SJ; Bai FH
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):665-73. PubMed ID: 26216028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etanercept in psoriasis treatment.
    Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines.
    Greenberg P
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii41-2. PubMed ID: 11890651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of Hepatic Encephalopathy.
    Jaffe A; Lim JK; Jakab SS
    Clin Liver Dis; 2020 May; 24(2):175-188. PubMed ID: 32245525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.